Clinical Trial

Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)

Name: Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL) — clinical trial record (NCT07247370)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: KET-DUAL

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

To assess the safety, feasibility and preliminary efficacy of ketamine-enhanced therapy (KET) for alcohol use disorder (AUD) and comorbid major depressive disorder (MDD) in an open-label, single arm, pilot clinical trial.

Trial Details

NCT Number	NCT07247370
Lead Sponsor	South West Sydney Local Health District Collaborators: University of Sydney
Conditions	Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD), Comorbidities and Coexisting Conditions
Enrollment	20 participants
Start Date	2025-12-10
Primary Completion	2027-04-10 (estimated)
Study Completion	2027-12-10 (estimated)
Updated on ClinicalTrials.gov	2025-11-25